Andere Sprachen Dr. Reddy's Laboratories Limited

Aktien

945997

INE089A01023

DRREDDY

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:50 26.04.2024			% 5 Tage	% 1. Jan.
6 253 ^INR	+0,58 %		+5,23 %	+7,85 %

26.04.	Asiatische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Freitagshandel höher und beenden die Woche mit einem Plus von 3,5%	MT
25.04.	Tech-Aktien führen asiatische Aktien an, die in den USA gehandelt werden, da American Depositary Receipts im Donnerstagshandel niedriger notieren	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%	26.04.
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	25.04.
Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories	25.04.
Banking Stocks Lift Indian Equities Higher	25.04.
Dr. Reddy's Laboratories Names CEO-North America	25.04.
Dr. Reddy's Laboratories Limited Announces Executive Changes	25.04.
Dr. Reddy's Laboratories Limited and Nestle India Limited Enter into Joint Venture Agreement for Investment in Dr. Reddy's Nutraceuticals Limited	25.04.
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation	24.04.
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US	24.04.
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns	23.04.
Dr Reddy Laboratories : . Reddy’s issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K	23.04.
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	23.04.
Dr Reddy Laboratories : Corporate_Governance_Report- March 31_2024	22.04.
Dr Reddy Laboratories : . Reddy's launches Condition Management programme ‘DailyBloom™ IBS’, India’s first-ever digital integrated care plan to manage Irritable Bowel Synome - Form 6-K	19.04.
Dr. Reddy's Labortories Launches Care Plan for IBS Patients	19.04.
India's Biocon developing its own version of Wegovy, clinical trial likely next year	18.04.
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	18.04.
Dr. Reddy's Laboratories Limited Receives an Order from the Commissioner of CGST,, Chandigarh	18.04.
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading	17.04.
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday	16.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dr. Reddy's Laboratories Limited

Aktien

945997

INE089A01023

DRREDDY

Andere Sprachen

Filter